Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies.

Balendra, R; Moens, TG; Isaacs, AM; (2017) Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies. EMBO Mol Med 10.15252/emmm.201707848 .

http://ift.tt/2ruirDi